Literature DB >> 30658876

Pentraxin-3: A strong novel biochemical marker for appendicitis in children.

Mustafa Onur Oztan1, Aysegul Aksoy Gokmen2, Tunc Ozdemir3, Tuba Müderris4, Selcuk Kaya2, Gokhan Koyluoglu5.   

Abstract

INTRODUCTION: Appendicitis is the most common surgical disease evaluated by pediatric surgeons in the emergency department. Despite the history, physical examination, laboratory tests and imaging methods, the misdiagnosis may be observed often in children. Pentraxin-3 (PTX-3) is an acute phase protein which is produced directly in the inflammatory tissue. Our aim was to investigate the diagnostic value of PTX-3 levels in appendicitis in pediatric patients and compare it with the other serum parameters.
METHODS: Eighty-eight patients (aged <18 years) were included in this study [Group 1 (n = 28) healthy volunteers, Group 2 (n = 28) patients with non-specific abdominal pain, Group 3 (n = 34) patients underwent appendectomy]. Serum white blood cell (WBC), absolute neutrophil count (ANC), neutrophil/lymphocyte ratio (NLR), C-reactive protein (CRP) and PTX-3 values were measured.
RESULTS: Median serum levels of WBC were higher in Group 2 and 3 than Group 1. ANS, NLR, CRP and PTX-3 were higher in Group 2 than Group 1 and were higher in Group 3 than the other groups. The highest sensitivity was found in NLR >3.5 [94.1 (95% CI = 80.3-99.3)] and PTX-3 > 5.6 ng/mL [91.8 (95% CI = 76.3-98.1)]. PTX-3 has the highest specificity among all of the parameters [90.7 (95% CI = 79.7-96.9)]. The area under the ROC curve showed that the diagnostic value of PTX-3 was greater than any other parameter [0.979 (95% CI = 0.92-0.99)].
CONCLUSION: In this study, we have shown that PTX-3 is very useful with high sensitivity and specificity in the diagnosis of appendicitis compared to WBC, ANS, NLR and CRP as a first in the literature.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appendicitis; Biomarker; C-reactive protein; Pediatric; Pentraxin-3

Mesh:

Substances:

Year:  2019        PMID: 30658876     DOI: 10.1016/j.ajem.2019.01.010

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

1.  Serum pentraxin-3 follows a logarithmic distribution particularly at low expected levels.

Authors:  Ufuk İlgen; Müçteba Enes Yayla; Cenk Gökalp; Hakan Emmungil; Nurşen Düzgün
Journal:  Int Wound J       Date:  2019-08-16       Impact factor: 3.315

2.  Utility of Pentraxin-3 as a biomarker for diagnosis of acute appendicitis: a systematic review and meta-analysis.

Authors:  Sachit Anand; Niklas Pakkasjärvi; Minu Bajpai; Nellai Krishnan; Chandramouli Goswami; Janne S Suominen; Devendra Kumar Yadav; Prabudh Goel
Journal:  Pediatr Surg Int       Date:  2022-06-15       Impact factor: 2.003

3.  Postoperative kinetics of pentraxin 3 (PTX3) after congenital heart surgery with cardiopulmonary bypass in pediatric patients.

Authors:  Radoslaw Jaworski; Katarzyna Dzierzanowska-Fangrat; Renata Grzywa-Czuba; Andrzej Kansy
Journal:  Perioper Med (Lond)       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.